Add us as a preferred source
Antoine Pivron of Withings Health Solutions joins the Healthcare Today Podcast to talk about how new models of care are shaping the next phase of GLP-1 therapy.
In this week’s Healthcare Today Podcast, we’re joined by Antoine Pivron, Vice President of Withings Health Solutions, where he leads the global B2B healthcare division across Europe and the US, working with more than 300 healthcare partners and supporting more than one million patients in remote monitoring programmes.
Today, we’re talking about GLP-1 therapies, the weight-loss drugs that have captured global attention. But beyond the headlines about shedding pounds, there’s a bigger conversation unfolding about how we monitor, engage and support patients over the long term.
Antoine’s organisation is working in partnership with Novo Nordisk and has also partnered with Juniper in the UK, bringing together pharmaceutical expertise and hardware technology.
In this episode, we’ll explore how remote patient monitoring, body composition data, and new models of care are shaping the next phase of GLP-1 therapy, and what this means for patients, clinicians and healthcare systems…
